Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

Journal: Science Translational Medicine

Published: 2018-02-21

DOI: 10.1126/scitranslmed.aam7729

Affiliations: 25

Authors: 49

Go to article
Institutions FC
University Medical Center Freiburg, Germany 0.35
Faculty of Medicine, Uni Freiburg, Germany 0.12
Center for Chronic Immunodeficiency (CCI), Uni Freiburg, Germany 0.07
DKTK Partner Site Freiburg, Germany 0.05
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0.05
Faculty of Biology, Uni Freiburg, Germany 0.05
Max Planck Institute of Immunobiology and Epigenetics (MPI-IE), Germany 0.04
University Medical Center Hamburg-Eppendorf (UKE), UHH, Germany 0.04
Institute of Molecular Medicine and Cell Research, Uni Freiburg, Germany 0.04
Cluster of Excellence - Center for Biological Signalling Studies (BIOSS), Uni Freiburg, Germany 0.03
QIMR Berghofer Department of Immunology, Australia 0.02
Vita-Salute San Raffaele University (UniSR), Italy 0.02
San Raffaele Scientific Institute, Italy 0.02
Division of Blood and Marrow Transplantation, UMN, United States of America (USA) 0.02
The University of Queensland (UQ), Australia 0.01
Royal Brisbane and Women's Hospital (RBWH), Australia 0.01
Department of Haematology and Medical Oncology, FSU, Germany 0.01
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Germany 0.01
School of Medicine (SOM), UQ, Australia 0.01
Spemann Graduate School of Biology and Medicine (SGBM), Uni Freiburg, Germany 0.01
Institute for Cardiogenetics, University of Lübeck, Germany 0.01
Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Germany 0.01